var data={"title":"Symptoms of hypermagnesemia","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Symptoms of hypermagnesemia</div><dl id=\"topicContributors\"><dt><span> </span>Authors:</dt><dd><a href=\"https://www.uptodate.com/contents/symptoms-of-hypermagnesemia/contributors\" class=\"contributor contributor_credentials\">Alan S L Yu, MB, BChir</a></dd><dd><a href=\"https://www.uptodate.com/contents/symptoms-of-hypermagnesemia/contributors\" class=\"contributor contributor_credentials\">Aditi Gupta, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/symptoms-of-hypermagnesemia/contributors\" class=\"contributor contributor_credentials\">Stanley Goldfarb, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/symptoms-of-hypermagnesemia/contributors\" class=\"contributor contributor_credentials\">Albert Q Lam, MD</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/symptoms-of-hypermagnesemia/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Nov 13, 2017.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1836851743\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Hypermagnesemia is an uncommon problem in the absence of magnesium administration or renal failure. (See <a href=\"topic.htm?path=causes-and-treatment-of-hypermagnesemia\" class=\"medical medical_review\">&quot;Causes and treatment of hypermagnesemia&quot;</a>.)</p><p>When it occurs, the elevation in the plasma magnesium concentration is usually mild (&lt;3 <span class=\"nowrap\">mEq/L,</span> 3.6 <span class=\"nowrap\">mg/dL,</span> or 1.5 <span class=\"nowrap\">mmol/L)</span> and the patient is asymptomatic. However, clinical symptoms may be seen when the plasma magnesium concentration exceeds 4 <span class=\"nowrap\">mEq/L</span> (4.8 <span class=\"nowrap\">mg/dL</span> or 2 <span class=\"nowrap\">mmol/L)</span>.</p><p>The clinical manifestations of hypermagnesemia are discussed in this topic. The regulation of magnesium balance and the causes and treatment of hypermagnesemia are presented elsewhere. (See <a href=\"topic.htm?path=regulation-of-magnesium-balance\" class=\"medical medical_review\">&quot;Regulation of magnesium balance&quot;</a> and <a href=\"topic.htm?path=causes-and-treatment-of-hypermagnesemia\" class=\"medical medical_review\">&quot;Causes and treatment of hypermagnesemia&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">OVERVIEW OF SYMPTOMS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The approximate relation between clinical manifestations and the degree of hypermagnesemia can be summarized as follows:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Plasma magnesium concentration 4 to 6 <span class=\"nowrap\">mEq/L</span> (4.8 to 7.2 <span class=\"nowrap\">mg/dL</span> or 2 to 3 <span class=\"nowrap\">mmol/L)</span> &ndash; Nausea, flushing, headache, lethargy, drowsiness, and diminished deep tendon reflexes.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Plasma magnesium concentration 6 to 10 <span class=\"nowrap\">mEq/L</span> (7.2 to 12 <span class=\"nowrap\">mg/dL</span> or 3 to 5 <span class=\"nowrap\">mmol/L)</span> &ndash; Somnolence, hypocalcemia, absent deep tendon reflexes, hypotension, bradycardia, and ECG changes.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Plasma magnesium concentration above 10 <span class=\"nowrap\">mEq/L</span> (12 <span class=\"nowrap\">mg/dL</span> or 5 <span class=\"nowrap\">mmol/L)</span> &ndash; Muscle paralysis leading to flaccid quadriplegia, apnea and respiratory failure, complete heart block, and cardiac arrest. In most cases, respiratory failure precedes cardiac collapse.</p><p/><p>Most of the symptoms can be divided into three categories: neuromuscular effects, cardiovascular effects, and hypocalcemia. (See <a href=\"#H2\" class=\"local\">'Neuromuscular effects'</a> below and <a href=\"#H3\" class=\"local\">'Cardiovascular effects'</a> below and <a href=\"#H4\" class=\"local\">'Hypocalcemia'</a> below.)</p><p class=\"headingAnchor\" id=\"H2\"><span class=\"h1\">NEUROMUSCULAR EFFECTS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Neuromuscular toxicity is the most consistently observed complication of hypermagnesemia. Increased magnesium decreases impulse transmission across the neuromuscular junction, producing a curare-like effect [<a href=\"https://www.uptodate.com/contents/symptoms-of-hypermagnesemia/abstract/1,2\" class=\"abstract_t\">1,2</a>]. The initial clinical manifestation of this problem is diminished deep tendon reflexes, which are usually first noted when the plasma magnesium concentration reaches 4 to 6 <span class=\"nowrap\">mEq/L</span> (4.8 to 7.2 <span class=\"nowrap\">mg/dL</span> or 2 to 3 <span class=\"nowrap\">mmol/L)</span>. More severe hypermagnesemia can result in somnolence; loss of deep tendon reflexes; and muscle paralysis, potentially leading to flaccid quadriplegia and, since smooth muscle function is also impaired, decreased respiration and eventual apnea. Parasympathetic blockade inducing fixed and dilated pupils, thereby mimicking a central brainstem herniation syndrome, can also be seen in this setting [<a href=\"https://www.uptodate.com/contents/symptoms-of-hypermagnesemia/abstract/3\" class=\"abstract_t\">3</a>].</p><p class=\"headingAnchor\" id=\"H3\"><span class=\"h1\">CARDIOVASCULAR EFFECTS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Magnesium is an effective calcium channel blocker both extracellularly and intracellularly; in addition, intracellular magnesium profoundly blocks several cardiac potassium channels [<a href=\"https://www.uptodate.com/contents/symptoms-of-hypermagnesemia/abstract/1\" class=\"abstract_t\">1</a>]. These changes can combine to impair cardiovascular function. Hypotension, conduction defects, and bradycardia begin to appear at a plasma magnesium concentration above 4 to 5 <span class=\"nowrap\">mEq/L</span> (4.8 to 6 <span class=\"nowrap\">mg/dL</span> or 2 to 2.5 <span class=\"nowrap\">mmol/L)</span> [<a href=\"https://www.uptodate.com/contents/symptoms-of-hypermagnesemia/abstract/1\" class=\"abstract_t\">1</a>]. Electrocardiogram (ECG) changes are usually seen at concentrations of 5 to 10 <span class=\"nowrap\">mEq/L</span> (6 to 12 <span class=\"nowrap\">mg/dL</span> or 2.5 to 5 <span class=\"nowrap\">mmol/L)</span>. These changes include prolongation of the P-R interval, an increase in QRS duration, and an increase in Q-T interval. Complete heart block and cardiac arrest may occur at a plasma magnesium concentration above 15 <span class=\"nowrap\">mEq/L</span> (18 <span class=\"nowrap\">mg/dL</span> or 7.5 <span class=\"nowrap\">mmol/L)</span>.</p><p>In a cross-sectional study of over 10,000 critically ill patients, hypermagnesemia was independently and significantly associated with both lower systolic blood pressures and intravenous vasopressor requirements during the first 24 hours of care in the intensive care unit [<a href=\"https://www.uptodate.com/contents/symptoms-of-hypermagnesemia/abstract/4\" class=\"abstract_t\">4</a>]. The effect of magnesium on blood pressure may be mediated by vasorelaxation [<a href=\"https://www.uptodate.com/contents/symptoms-of-hypermagnesemia/abstract/5,6\" class=\"abstract_t\">5,6</a>] and via its effects on transient receptor potential melastatin (TRPM) [<a href=\"https://www.uptodate.com/contents/symptoms-of-hypermagnesemia/abstract/7\" class=\"abstract_t\">7</a>] and aldosterone [<a href=\"https://www.uptodate.com/contents/symptoms-of-hypermagnesemia/abstract/8\" class=\"abstract_t\">8</a>].</p><p class=\"headingAnchor\" id=\"H4\"><span class=\"h1\">HYPOCALCEMIA</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Moderate hypermagnesemia can inhibit the secretion of parathyroid hormone (PTH), leading to a reduction in the plasma calcium concentration [<a href=\"https://www.uptodate.com/contents/symptoms-of-hypermagnesemia/abstract/9\" class=\"abstract_t\">9</a>]. This effect has been described after magnesium infusion in normal subjects and in pregnant women with eclampsia [<a href=\"https://www.uptodate.com/contents/symptoms-of-hypermagnesemia/abstract/10-13\" class=\"abstract_t\">10-13</a>]. The fall in the plasma calcium concentration is usually transient and produces no symptoms; in some cases, however, electrocardiogram (ECG) abnormalities associated with hypocalcemia can be seen. In the long term, hypermagnesemia can contribute to osteomalacic renal osteodystrophy and adynamic bone disease, especially in patients with kidney disease. (See <a href=\"topic.htm?path=overview-of-chronic-kidney-disease-mineral-and-bone-disorder-ckd-mbd\" class=\"medical medical_review\">&quot;Overview of chronic kidney disease-mineral and bone disorder (CKD-MBD)&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H5\"><span class=\"h1\">OTHER</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Hypermagnesemia may be associated with nonspecific early symptoms such as nausea, vomiting, and flushing. In addition, hyperkalemia has been described in three pregnant women following parenteral magnesium administration [<a href=\"https://www.uptodate.com/contents/symptoms-of-hypermagnesemia/abstract/14,15\" class=\"abstract_t\">14,15</a>]. The frequency of this complication is uncertain since the plasma potassium concentration is not routinely monitored in this setting. The mechanism responsible for the hyperkalemia is unclear, but decreased urinary potassium excretion due to magnesium-induced blockade of renal potassium channels may be involved [<a href=\"https://www.uptodate.com/contents/symptoms-of-hypermagnesemia/abstract/1\" class=\"abstract_t\">1</a>]. Hypermagnesemia can also cause <span class=\"nowrap\">and/or</span> exacerbate pruritus in dialysis patients, which is possibly due to altered nerve conduction velocity [<a href=\"https://www.uptodate.com/contents/symptoms-of-hypermagnesemia/abstract/16\" class=\"abstract_t\">16</a>].</p><p>Side effects associated with the use of magnesium in pregnant women are discussed elsewhere. (See <a href=\"topic.htm?path=preeclampsia-management-and-prognosis#H23\" class=\"medical medical_review\">&quot;Preeclampsia: Management and prognosis&quot;, section on 'Toxicity'</a> and <a href=\"topic.htm?path=inhibition-of-acute-preterm-labor#H18\" class=\"medical medical_review\">&quot;Inhibition of acute preterm labor&quot;, section on 'Maternal and fetal side effects'</a>.)</p><p class=\"headingAnchor\" id=\"H1880970257\"><span class=\"h1\">SOCIETY GUIDELINE LINKS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See <a href=\"topic.htm?path=society-guideline-links-fluid-and-electrolyte-disorders\" class=\"medical medical_society_guidelines\">&quot;Society guideline links: Fluid and electrolyte disorders&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H25337260\"><span class=\"h1\">SUMMARY</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Neuromuscular toxicity is the most common complication of hypermagnesemia. Symptoms range from diminished deep tendon reflexes when the plasma magnesium concentration reaches 4 to 6 <span class=\"nowrap\">mEq/L</span> (4.8 to 7.2 <span class=\"nowrap\">mg/dL</span> or 2 to 3 <span class=\"nowrap\">mmol/L)</span> to somnolence, loss of deep tendon reflexes, and muscle paralysis. (See <a href=\"#H2\" class=\"local\">'Neuromuscular effects'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Bradycardia and hypotension may occur at a plasma magnesium concentration above 4 to 5 <span class=\"nowrap\">mEq/L</span> (4.8 to 6 <span class=\"nowrap\">mg/dL</span> or 2 to 2.5 <span class=\"nowrap\">mmol/L)</span>. Observed electrocardiogram (ECG) changes include prolongation of the P-R interval, an increase in QRS duration, and an increase in Q-T interval. Complete heart block and cardiac arrest may occur at a plasma magnesium concentration above 15 <span class=\"nowrap\">mEq/L</span> (18 <span class=\"nowrap\">mg/dL</span> or 7.5 <span class=\"nowrap\">mmol/L)</span>. (See <a href=\"#H3\" class=\"local\">'Cardiovascular effects'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Hypermagnesemia may inhibit the secretion of parathyroid hormone (PTH), causing transient hypocalcemia. (See <a href=\"#H4\" class=\"local\">'Hypocalcemia'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Hypermagnesemia may also cause nonspecific symptoms such as nausea, vomiting, and flushing. (See <a href=\"#H5\" class=\"local\">'Other'</a> above.)</p><p/><p class=\"headingAnchor\" id=\"H527940343\"><span class=\"h1\">ACKNOWLEDGMENT</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The editorial staff at UpToDate would like to acknowledge Zalman S Agus, MD, who contributed to an earlier version of this topic review.</p></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/symptoms-of-hypermagnesemia/abstract/1\" class=\"nounderline abstract_t\">Agus ZS, Morad M. Modulation of cardiac ion channels by magnesium. Annu Rev Physiol 1991; 53:299.</a></li><li><a href=\"https://www.uptodate.com/contents/symptoms-of-hypermagnesemia/abstract/2\" class=\"nounderline abstract_t\">Krendel DA. Hypermagnesemia and neuromuscular transmission. Semin Neurol 1990; 10:42.</a></li><li><a href=\"https://www.uptodate.com/contents/symptoms-of-hypermagnesemia/abstract/3\" class=\"nounderline abstract_t\">Rizzo MA, Fisher M, Lock JP. Hypermagnesemic pseudocoma. Arch Intern Med 1993; 153:1130.</a></li><li><a href=\"https://www.uptodate.com/contents/symptoms-of-hypermagnesemia/abstract/4\" class=\"nounderline abstract_t\">Celi LA, Scott DJ, Lee J, et al. Association of hypermagnesemia and blood pressure in the critically ill. J Hypertens 2013; 31:2136.</a></li><li><a href=\"https://www.uptodate.com/contents/symptoms-of-hypermagnesemia/abstract/5\" class=\"nounderline abstract_t\">Laurant P, Berthelot A. Influence of endothelium on Mg(2+)-induced relaxation in noradrenaline-contracted aorta from DOCA-salt hypertensive rat. Eur J Pharmacol 1994; 258:167.</a></li><li><a href=\"https://www.uptodate.com/contents/symptoms-of-hypermagnesemia/abstract/6\" class=\"nounderline abstract_t\">Laurant P, Touyz RM. Physiological and pathophysiological role of magnesium in the cardiovascular system: implications in hypertension. J Hypertens 2000; 18:1177.</a></li><li><a href=\"https://www.uptodate.com/contents/symptoms-of-hypermagnesemia/abstract/7\" class=\"nounderline abstract_t\">Schmitz C, Perraud AL, Johnson CO, et al. Regulation of vertebrate cellular Mg2+ homeostasis by TRPM7. Cell 2003; 114:191.</a></li><li><a href=\"https://www.uptodate.com/contents/symptoms-of-hypermagnesemia/abstract/8\" class=\"nounderline abstract_t\">Sontia B, Montezano AC, Paravicini T, et al. Downregulation of renal TRPM7 and increased inflammation and fibrosis in aldosterone-infused mice: effects of magnesium. Hypertension 2008; 51:915.</a></li><li><a href=\"https://www.uptodate.com/contents/symptoms-of-hypermagnesemia/abstract/9\" class=\"nounderline abstract_t\">Navarro-Gonz&aacute;lez JF. Magnesium in dialysis patients: serum levels and clinical implications. Clin Nephrol 1998; 49:373.</a></li><li><a href=\"https://www.uptodate.com/contents/symptoms-of-hypermagnesemia/abstract/10\" class=\"nounderline abstract_t\">Cholst IN, Steinberg SF, Tropper PJ, et al. The influence of hypermagnesemia on serum calcium and parathyroid hormone levels in human subjects. N Engl J Med 1984; 310:1221.</a></li><li><a href=\"https://www.uptodate.com/contents/symptoms-of-hypermagnesemia/abstract/11\" class=\"nounderline abstract_t\">Suzuki K, Nonaka K, Kono N, et al. Effects of the intravenous administration of magnesium sulfate on corrected serum calcium level and nephrogenous cyclic AMP excretion in normal human subjects. Calcif Tissue Int 1986; 39:304.</a></li><li><a href=\"https://www.uptodate.com/contents/symptoms-of-hypermagnesemia/abstract/12\" class=\"nounderline abstract_t\">Monif GR, Savory J. Iatrogenic maternal hypocalcemia following magnesium sulfate therapy. JAMA 1972; 219:1469.</a></li><li><a href=\"https://www.uptodate.com/contents/symptoms-of-hypermagnesemia/abstract/13\" class=\"nounderline abstract_t\">Eisenbud E, LoBue CC. Hypocalcemia after therapeutic use of magnesium sulfate. Arch Intern Med 1976; 136:688.</a></li><li><a href=\"https://www.uptodate.com/contents/symptoms-of-hypermagnesemia/abstract/14\" class=\"nounderline abstract_t\">Spital A, Greenwell R. Severe hyperkalemia during magnesium sulfate therapy in two pregnant drug abusers. South Med J 1991; 84:919.</a></li><li><a href=\"https://www.uptodate.com/contents/symptoms-of-hypermagnesemia/abstract/15\" class=\"nounderline abstract_t\">Iglesias MH, Giesbrecht EM, von Dadelszen P, Magee LA. Postpartum hyperkalemia associated with magnesium sulfate. Hypertens Pregnancy 2011; 30:481.</a></li><li><a href=\"https://www.uptodate.com/contents/symptoms-of-hypermagnesemia/abstract/16\" class=\"nounderline abstract_t\">Carmichael AJ, McHugh MM, Martin AM, Farrow M. Serological markers of renal itch in patients receiving long term haemodialysis. Br Med J (Clin Res Ed) 1988; 296:1575.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 849 Version 18.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H25337260\"><span>SUMMARY</span></a></li><li><a href=\"#H1836851743\" id=\"outline-link-H1836851743\">INTRODUCTION</a></li><li><a href=\"#H1\" id=\"outline-link-H1\">OVERVIEW OF SYMPTOMS</a></li><li><a href=\"#H2\" id=\"outline-link-H2\">NEUROMUSCULAR EFFECTS</a></li><li><a href=\"#H3\" id=\"outline-link-H3\">CARDIOVASCULAR EFFECTS</a></li><li><a href=\"#H4\" id=\"outline-link-H4\">HYPOCALCEMIA</a></li><li><a href=\"#H5\" id=\"outline-link-H5\">OTHER</a></li><li><a href=\"#H1880970257\" id=\"outline-link-H1880970257\">SOCIETY GUIDELINE LINKS</a></li><li><a href=\"#H25337260\" id=\"outline-link-H25337260\">SUMMARY</a></li><li><a href=\"#H527940343\" id=\"outline-link-H527940343\">ACKNOWLEDGMENT</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=causes-and-treatment-of-hypermagnesemia\" class=\"medical medical_review\">Causes and treatment of hypermagnesemia</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=inhibition-of-acute-preterm-labor\" class=\"medical medical_review\">Inhibition of acute preterm labor</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-chronic-kidney-disease-mineral-and-bone-disorder-ckd-mbd\" class=\"medical medical_review\">Overview of chronic kidney disease-mineral and bone disorder (CKD-MBD)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=preeclampsia-management-and-prognosis\" class=\"medical medical_review\">Preeclampsia: Management and prognosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=regulation-of-magnesium-balance\" class=\"medical medical_review\">Regulation of magnesium balance</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=society-guideline-links-fluid-and-electrolyte-disorders\" class=\"medical medical_society_guidelines\">Society guideline links: Fluid and electrolyte disorders</a></li></ul></div></div>","javascript":null}